Your browser doesn't support javascript.
loading
Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia.
Sun, Qian; Wang, Li; Zhu, Hua-Yuan; Miao, Yi; Wu, Wei; Liang, Jin-Hua; Cao, Lei; Xia, Yi; Wu, Jia-Zhu; Wang, Yan; Wang, Rong; Fan, Lei; Xu, Wei; Li, Jian-Yong.
Afiliación
  • Sun Q; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
  • Wang L; Collaborative Innovation Center for Cancer Personalized Medicine, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Zhu HY; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
  • Miao Y; Collaborative Innovation Center for Cancer Personalized Medicine, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Wu W; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
  • Liang JH; Collaborative Innovation Center for Cancer Personalized Medicine, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Cao L; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
  • Xia Y; Collaborative Innovation Center for Cancer Personalized Medicine, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Wu JZ; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
  • Wang Y; Collaborative Innovation Center for Cancer Personalized Medicine, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Wang R; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
  • Fan L; Collaborative Innovation Center for Cancer Personalized Medicine, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Xu W; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
  • Li JY; Collaborative Innovation Center for Cancer Personalized Medicine, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Chin Med J (Engl) ; 132(5): 525-533, 2019 Mar 05.
Article en En | MEDLINE | ID: mdl-30741830
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Anticuerpos Antinucleares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Chin Med J (Engl) Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Anticuerpos Antinucleares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Chin Med J (Engl) Año: 2019 Tipo del documento: Article País de afiliación: China